Authors


FG Clean Wipes

Latest:

Are You Ready For USP ?

Download this application note to learn about hazardous drugs basics - listing through storage, engineering controls and training programs, and why you shouldn’t wait, regardless of initial enforcement for your facility.


Jennifer C. Rea, PhD

Latest:

High-Throughput Multi-Product Liquid Chromatography for Characterization of Monoclonal Antibodies

These new analytical methods can reduce analysis and product development time.


Ioscani Jiménez del Val

Latest:

Leveraging Computational Models of Glycosylation for Biopharma QA

Close collaboration between academic and industrial groups is vital to ensuring glycosylation models are fit for deployment.


Elizabeth Rivera

Latest:

Cleaning Chromatography Resin Residues from Surfaces

Laboratory test methods evaluate cleaning agents and cleaning process design for removing resin residues from the surfaces of non-dedicated chromatography columns systems.


Jeffrey R. Mazzeo, PhD

Latest:

The Role of Analytical Science in the Debate over Biosimilars

Both innovator and generics companies are using analytics to support comparability arguments.


Ziling Lu

Latest:

Next Generation Peptide Mapping with Ultra Performance Liquid Chromatography

Ultra performance liquid chromatography (UPLC) is a new category of liquid chromatography that researchers are using to increase resolution, speed, and sensitivity in a variety of applications. These benefits result from packing columns with 1.7 ?m particles and using instruments that are optimized for such columns.



Joe Sheffer

Latest:

CMC Due Diligence for Accelerated Biologic Drug Development and Manufacturing

The growing trend of partnerships between small biotech companies and CDMOs makes the need for conducting CMC due diligence increasingly important.


Yanhuai (Richard) Ding

Latest:

Points to Consider for Continuous Downstream Bioprocessing

It is critical to evaluate specific considerations, from design to application, for the benefit of downstream bioprocessing and manufacturing.


Andy Racher

Latest:

Complex and Customized: Manufacturing New Molecular Formats

Increasingly complex monoclonal antibody molecules will require the right “tool box” for scaling up manufacturing.


Kevin Zen

Latest:

CMC Due Diligence for Accelerated Biologic Drug Development and Manufacturing

The growing trend of partnerships between small biotech companies and CDMOs makes the need for conducting CMC due diligence increasingly important.


Tom Burton

Latest:

The State of the Used-Equipment Market

Today, there is a global adoption of buying and selling used equipment. This article reviews what organizations should look for when considering the purchase of used equipment.


Alex Praseuth

Latest:

CMC Due Diligence for Accelerated Biologic Drug Development and Manufacturing

The growing trend of partnerships between small biotech companies and CDMOs makes the need for conducting CMC due diligence increasingly important.


Hemant Kumar

Latest:

Antibody Purification Process Development and Manufacturing

Downstream process development and manufacturing play a crucial role to ensure safety, quality, identity, purity, and efficacy.


Peggy Marino

Latest:

CMC Due Diligence for Accelerated Biologic Drug Development and Manufacturing

The growing trend of partnerships between small biotech companies and CDMOs makes the need for conducting CMC due diligence increasingly important.


Arnold G. Vulto

Latest:

Challenges with Successful Commercialization of Biosimilars

This article presents some key differences between the US and European regulation of biosimilars, including naming conventions and pharmacovigilance of biosimilars, and the impact of biosimilars on commercialization and affordability of biotherapeutics.


James G. Stevenson

Latest:

Challenges with Successful Commercialization of Biosimilars

This article presents some key differences between the US and European regulation of biosimilars, including naming conventions and pharmacovigilance of biosimilars, and the impact of biosimilars on commercialization and affordability of biotherapeutics.


Vinod P. Shah

Latest:

Challenges with Successful Commercialization of Biosimilars

This article presents some key differences between the US and European regulation of biosimilars, including naming conventions and pharmacovigilance of biosimilars, and the impact of biosimilars on commercialization and affordability of biotherapeutics.


Brigitte Barbeau

Latest:

Plants As an Innovative and Accelerated Vaccine-Manufacturing Solution

A plant-based expression system could provide greater speed and capacity at a comparatively low cost.


Tracy Thompson

Latest:

Bioengineered Protein A Polymer Beads for High-Affinity Antibody Purification

The authors discuss an alternative to traditional Protein A resins.



Tina Sturgill

Latest:

Outsourcing Lean Quality Manufacturing

Rapid microbial screening provided by contract laboratories can save companies time and money.


Timothy Korwan

Latest:

New Strategies for Managing Single-Use Components

Dual-sourcing and redundant manufacturing capabilities are crucial in a single-use supply chain strategy, but must be applied correctly.


Jay Harp

Latest:

New Strategies for Managing Single-Use Components

Dual-sourcing and redundant manufacturing capabilities are crucial in a single-use supply chain strategy, but must be applied correctly.


Deborah R. Cohen

Latest:

Automated Concentration and Diafiltration of Multiple siRNA Samples

Project: transfer a manual concentration/diafiltration process for siRNA production.


Andreas Nixdorf

Latest:

Extractables and Leachables: Determining Risk in Single-Use Systems

As SUS become prevalent in the biologics industry, the question of safety becomes increasingly important.


Libing Tian

Latest:

Catalytic Site Analysis and Characterization of a Solvent-Tolerant Aldo-Keto Reductase

In this study, a novel aldo-keto reductase was cloned and purified, and its important conserved sites were analyzed.


Wei Jiang

Latest:

Catalytic Site Analysis and Characterization of a Solvent-Tolerant Aldo-Keto Reductase

In this study, a novel aldo-keto reductase was cloned and purified, and its important conserved sites were analyzed.


Rui Pei

Latest:

Catalytic Site Analysis and Characterization of a Solvent-Tolerant Aldo-Keto Reductase

In this study, a novel aldo-keto reductase was cloned and purified, and its important conserved sites were analyzed.


Shu-Feng Zhou

Latest:

Catalytic Site Analysis and Characterization of a Solvent-Tolerant Aldo-Keto Reductase

In this study, a novel aldo-keto reductase was cloned and purified, and its important conserved sites were analyzed.

© 2025 MJH Life Sciences

All rights reserved.